How should pharma companies respond to the current “hinge moment” where new technologies are enabling breakthroughs in drug discovery, manufacturing and customer engagement? Maria Whitman’s guest Alex Koehler, vice president and head of digital technology and innovation at Amgen, believes it’s time to be bold and move faster to capitalize on this opportunity. In this episode they discuss:
- How Amgen is using its Amgen India Center as an innovation hub to tackle key challenges
- How AI and data-driven insights can help personalize interactions, predict barriers and improve the patient journey and access to therapies
- How biopharma can transform to better serve patients through innovation and digital enablement
Transforming Biopharma